Global Wearable Heart Monitoring Devices Market Analysis Report 2023: Diagnostic and Monitoring Devices Lead the Market with Multiple Applications - Forecasts to 2032
Company Logo
Company Logo

Global Wearable Heart Monitoring Devices Market

Global Wearable Heart Monitoring Devices Market
Global Wearable Heart Monitoring Devices Market

Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Wearable Heart Monitoring Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

The global wearable heart monitoring devices market is expected to grow from $1.95 billion in 2022 to $2.19 billion in 2023 at a compound annual growth rate (CAGR) of 12.3%. The wearable heart monitoring devices market is expected to reach $3.43 billion in 2027 at a CAGR of 11.8%.

The research report on the wearable heart monitoring devices market presents comprehensive statistics and insights into this industry. It includes global market size, regional market shares, competitor analysis, detailed market segments, trends, opportunities, and other relevant data to assist businesses in thriving within the wearable heart monitoring devices sector.

One prominent trend in the wearable heart monitoring devices market is the adoption of advanced technologies. Leading companies in this space are introducing innovative products with cutting-edge technologies to enhance their market positions. For example, in February 2021, RhythMedix, a US-based medical equipment manufacturer, launched the next-generation RhythmStar, a wearable heart monitoring device designed for arrhythmia detection.

This device incorporates built-in cellular connectivity technology, allowing long-term remote monitoring without the need for a phone or additional communication equipment. It enables certified technicians to quickly analyze and diagnose cardiac irregularities by alerting clinicians when potentially dangerous arrhythmias are detected.

In January 2021, Boston Scientific, a US-based medical technology firm, acquired Preventice Solutions for approximately $925 million. This strategic acquisition has enabled Boston Scientific to expand its presence in the heart diagnostics and services vertical. It has also strengthened Boston Scientific's position in core cardiac rhythm management and electrophysiology, further solidifying its standing in the market. Preventice Solutions, the acquired company, specializes in manufacturing wearable heart sensors for remote patient monitoring.

The increasing prevalence of cardiovascular diseases (CVD) is anticipated to drive the growth of the wearable heart monitoring devices market in the future. CVDs encompass a range of heart abnormalities, such as atrial fibrillation, ventricular fibrillation, and atrioventricular block, which require long-term monitoring. Patients with cardiovascular conditions require wearable devices for continuous heart monitoring, which is crucial for tracking heart rate and detecting any irregularities.